Subscribe to RSS
DOI: 10.1055/a-2121-8878
Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study
Funding No funding was received for the completion of this study. S.R.T. received travel grant from the Alberta Children's' Hospital Research Institute to present the abstract of this study's findings at the Pediatric Academy Society meeting in April 2022, at Denver, Colorado, USA.

Abstract
Objective This study aimed to determine neurodevelopmental outcomes of preterm infants born at <29 weeks' gestational age (GA) with bronchopulmonary dysplasia and pulmonary hypertension (BPD–PH) at 18 to 24 months' corrected age (CA).
Study Design In this retrospective cohort study, preterm infants born at <29 weeks' GA between January 2016 and December 2019, admitted to level 3 neonatal intensive care units, who developed BPD and were evaluated at 18 to 24 months' CA in the neonatal follow-up clinics were included. We compared demographic characteristics and neurodevelopmental outcomes between the two groups: Group I: BPD with PH and Group II: BPD with no PH, using univariate and multivariate regression models. The primary outcome was a composite of death or neurodevelopmental impairment (NDI). NDI was defined as any Bayley-III score < 85 on one or more of the cognitive, motor, or language composite scores.
Results Of 366 eligible infants, 116 (Group I [BPD–PH] =7, Group II [BPD with no PH] = 109) were lost to follow-up. Of the remaining 250 infants, 51 in Group I and 199 in Group II were followed at 18 to 24 months' CA. Group I and Group II had median (interquartile range [IQR]) birthweights of 705 (325) and 815 g (317; p = 0.003) and median GAs (IQR) were 25 (2) and 26 weeks (2; p = 0.015) respectively. Infants in the BPD–PH group (Group I) were more likely to have mortality or NDI (adjusted odds ratio: 3.82; bootstrap 95% confidence interval; 1.44–40.87).
Conclusion BPD–PH in infants born at <29 weeks' GA is associated with increased odds of the composite outcome of death or NDI at 18 to 24 months' CA.
Key Points
-
Long-term neurodevelopmental follow-up of preterm infants born <29 weeks' GA.
-
Association of neurodevelopmental outcomes with BPD-associated PH.
-
Need for longitudinal follow-up of children with BPD-associated PH.
Keywords
preterm infants - bronchopulmonary dysplasia - pulmonary hypertension - neurodevelopmental outcomesNote
This project was previously presented at the Pediatric Academy Society meeting in April 2022 at Denver, CO.
Ethical Approval
The study was approved by the Conjoint Health Research Ethics Board of the University of Calgary and the UTMB Institutional Review Board, and the need for consent was waived as the study used deidentified data.
Authors' Contributions
All the authors have contributed to the study design, data acquisition, interpretation of results, reviewing the manuscript, and approval of the final version.
Publication History
Received: 31 January 2023
Accepted: 30 June 2023
Accepted Manuscript online:
03 July 2023
Article published online:
29 July 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Am J Perinatol 2016; 33 (11) 1076-1078
- 2 Beltempo MSP, Yoon EW, Chan P. Balachandran N and, Members of the Annual Report Review Committee. The Canadian Neonatal Network: Annual Report 2020. In. Toronto: Maternal-Infant Care Research Centre, Mount Sinai Hospital, Toronto, Ontario; 2020
- 3 Lee SK, Ye XY, Singhal N, De La Rue S, Lodha A, Shah PS. Canadian Neonatal Network. Higher altitude and risk of bronchopulmonary dysplasia among preterm infants. Am J Perinatol 2013; 30 (07) 601-606
- 4 Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 2006; 30 (04) 227-232
- 5 Davidson LM, Berkelhamer SK. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med 2017; 6 (01) 4
- 6 Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100 (03) 145-157
- 7 Lodha A, Sauvé R, Bhandari V. et al. Need for supplemental oxygen at discharge in infants with bronchopulmonary dysplasia is not associated with worse neurodevelopmental outcomes at 3 years corrected age. PLoS One 2014; 9 (03) e90843
- 8 Al-Ghanem G, Shah P, Thomas S. et al. Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. J Perinatol 2017; 37 (04) 414-419
- 9 Ambalavanan N, Mourani P. Pulmonary hypertension in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 2014; 100 (03) 240-246
- 10 Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002; 140 (03) 306-310
- 11 Marron MJ, Crisafi MA, Driscoll Jr JM. et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. Pediatrics 1992; 90 (03) 392-396
- 12 Rohana J, Boo NY, Chandran V, Sarvananthan R. Neurodevelopmental outcome of newborns with persistent pulmonary hypertension. Malays J Med Sci 2011; 18 (04) 58-62
- 13 Hilgendorff A, Apitz C, Bonnet D, Hansmann G. Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 2016; 102 (Suppl. 02) ii49-ii56
- 14 Choi EK, Shin SH, Kim EK, Kim HS. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age. BMC Pediatr 2019; 19 (01) 26
- 15 MacKenzie K, Cunningham K, Thomas S. et al. Incidence, risk factors, and outcomes of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Paediatr Child Health 2020; 25 (04) 222-227
- 16 Nakanishi H, Uchiyama A, Kusuda S. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J Perinatol 2016; 36 (10) 890-896
- 17 Klamer A, Lando A, Pinborg A, Greisen G. Ages and Stages Questionnaire used to measure cognitive deficit in children born extremely preterm. Acta Paediatr 2005; 94 (09) 1327-1329
- 18 Schonhaut L, Armijo I, Schönstedt M, Alvarez J, Cordero M. Validity of the ages and stages questionnaires in term and preterm infants. Pediatrics 2013; 131 (05) e1468-e1474
- 19 Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82 (04) 527-532
- 20 Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39 (04) 214-223
- 21 Bell MJ, Ternberg JL, Feigin RD. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (01) 1-7
- 22 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
- 23 Kwun Y, Kim SJ, Lee J. et al. Disease-specific growth charts of Marfan syndrome patients in Korea. J Korean Med Sci 2015; 30 (07) 911-916
- 24 Raimundo DSCJ, Vasco J, Viveiros E. Parental assessment on neurodevelopmental outcomes in children born late preterm at 2, 3, 5 and 8 years old. Arch Dis Child 2021; 106: 197-198